These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2830879

  • 1. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T.
    Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
    [Abstract] [Full Text] [Related]

  • 2. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 3. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 15; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 4. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr 15; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 5. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.
    J Clin Microbiol; 2006 Apr 15; 44(4):1459-67. PubMed ID: 16597877
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Apr 15; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 7. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov 15; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 8. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A, Corradini C, Venanzoni M, Cardi G, Bevere F, Barile G, Zompetta C, Frati L.
    J Exp Pathol; 1987 Nov 15; 3(4):471-7. PubMed ID: 2842480
    [Abstract] [Full Text] [Related]

  • 9. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O.
    Kroc Found Ser; 1985 Nov 15; 19():287-300. PubMed ID: 2999343
    [Abstract] [Full Text] [Related]

  • 10. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G, Bitzer M, Bross KJ, Brugger W, Boldt C, Hirsch FW, Weitzmann U, Löhr GW.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1837-43. PubMed ID: 6094138
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W, Cao SM, Huang QH, Li YH, Deng MQ.
    Ai Zheng; 2009 Jan 30; 28(1):57-9. PubMed ID: 19448418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P, Sutthent R, Vitavasiri A, Wasi C, Chantarakul N, Thongcharoen P.
    Southeast Asian J Trop Med Public Health; 1991 Sep 30; 22(3):326-31. PubMed ID: 1818381
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW, Rohwäder E, Chu IM, Tsang RK, Steinhagen K, Yeung AC, To KF, Chan PK.
    J Clin Virol; 2007 Dec 30; 40(4):284-8. PubMed ID: 17977062
    [Abstract] [Full Text] [Related]

  • 17. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981 Dec 30; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May 30; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 19. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
    Ammatuna P, de Thè G, Speciale R, Sammartano F, Arista S, Zerillo G.
    Microbiologica; 1988 Apr 30; 11(2):89-94. PubMed ID: 2841559
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):130-7. PubMed ID: 16979842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.